Oropharyngeal Squamous Cell Carcinoma — Trials

Oropharyngeal Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

263 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 93
Recruiting: 46
Ph III recruiting: 3
Growth YoY: —
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: 40.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (45)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03618654	Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma	completed	Early Phase 1	38	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER	1	May 15, 2025	clinicaltrials

Data updated 22 days agoSource updated May 15, 2025source: clinicaltrials